{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:23:46Z","timestamp":1759710226202,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.mehy.2021.110539","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:46:13Z","timestamp":1613868373000},"page":"110539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?"],"prefix":"10.1016","volume":"149","author":[{"given":"Hardeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phulen","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusuya","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Prajapat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mehy.2021.110539_b0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2021.110539_b0010","unstructured":"Gysi DM, Valle \u00cdD, Zitnik M, Ameli A, Gan X, Varol O, et al. Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19. ArXiv:200407229 [Cs, q-Bio, Stat] 2020."},{"key":"10.1016\/j.mehy.2021.110539_b0015","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.ijbiomac.2020.09.138","article-title":"Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)","volume":"163","author":"Ugurel","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.mehy.2021.110539_b0020","doi-asserted-by":"crossref","unstructured":"Sheybani Z, Dokoohaki MH, Negahdaripour M, Dehdashti M, Zolghadr H, Moghadami M, et al. The role of folic acid in the management of respiratory disease caused by COVID-19 2020. doi: 10.26434\/chemrxiv.12034980.v1.","DOI":"10.26434\/chemrxiv.12034980.v1"},{"key":"10.1016\/j.mehy.2021.110539_b0025","doi-asserted-by":"crossref","unstructured":"In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19 2020. doi: 10.21203\/rs.3.rs-31775\/v1.","DOI":"10.21203\/rs.3.rs-31775\/v1"},{"key":"10.1016\/j.mehy.2021.110539_b0030","doi-asserted-by":"crossref","first-page":"107716","DOI":"10.1016\/j.jmgm.2020.107716","article-title":"Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2","volume":"101","author":"Prajapat","year":"2020","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.mehy.2021.110539_b0035","doi-asserted-by":"crossref","unstructured":"Life-threatening course in coronavirus disease 2019 (COVID-19)_ Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? | Elsevier Enhanced Reader n.d. doi: 10.1016\/j.mehy.2020.110234.","DOI":"10.1016\/j.mehy.2020.110234"},{"key":"10.1016\/j.mehy.2021.110539_b0040","doi-asserted-by":"crossref","first-page":"110142","DOI":"10.1016\/j.mehy.2020.110142","article-title":"High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia","volume":"143","author":"Wiltshire","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2021.110539_b0045","doi-asserted-by":"crossref","unstructured":"Singh Y, Gupta G, Kazmi I, Al\u2010Abbasi FA, Negi P, Chellappan DK, et al. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatologic Therapy n.d.;n\/a:e13871. doi: 10.1111\/dth.13871.","DOI":"10.1111\/dth.13871"},{"issue":"1","key":"10.1016\/j.mehy.2021.110539_b0050","article-title":"Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.mehy.2021.110539_b0055","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.18632\/aging.102999","article-title":"Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.mehy.2021.110539_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14412\/2074-2711-2020-3-82-86","article-title":"The first experience with Angiovit in the combination treatment of acute COVID-19 infection","volume":"12","author":"Boyko","year":"2020","journal-title":"Neurol Neuropsychiatry Psychosomatics"},{"key":"10.1016\/j.mehy.2021.110539_b0065","first-page":"271","article-title":"Clinical characterization of 162 COVID-19 patients in Israel: preliminary report from a large tertiary center","volume":"22","author":"Itelman","year":"2020","journal-title":"Isr Med Assoc J"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721000578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721000578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:24:23Z","timestamp":1759692263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987721000578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":13,"alternative-id":["S0306987721000578"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110539","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110539"}}